METiS, an AI Drug Firm, Plans $200 Million IPO in Hong Kong

METiS Pharmaceuticals, an AI-driven drug delivery and discovery firm based in Hangzhou, is exploring the possibility of launching an initial public offering (IPO) in Hong Kong.
METiS Pharmaceuticals, an AI-driven drug delivery and discovery firm based in Hangzhou, is exploring the possibility of launching an initial public offering (IPO) in Hong Kong.
In a move that has sparked controversy, President Donald Trump has dismissed Shira Perlmutter, the head of the U.S. Copyright Office.
OpenAI, the company, has entered into intense negotiations with Microsoft to revise the terms of their multibillion-dollar partnership.
A U.S. senator has introduced a new bill aimed at restricting China's access to advanced semiconductor technology, particularly artificial intelligence (AI) chips.
Ex-Northvolt executives, Peter Carlsson and Siddharth Khullar, have launched a new venture, Aris Machina, focusing on AI-driven manufacturing.
Elon Musk's lawyer requested that a judge dismiss allegations made against Musk to damage OpenAI’s progress for his benefit.
Fidji Simo has announced she will join OpenAI as the new CEO of Applications, according to an official statement by Sam Altman.
OpenAI advances with Stargate project, which aims to be the backbone of the future global economy by building cutting-edge AI infrastructure.
Anthropic has launched a Web Search API that enhances its Claude AI models, enabling their AI models search the web for updated information.
Fastino, a Palo Alto-based startup, is disrupting the world of AI with a fresh approach to model architecture.